Sign up to The Irish Times Archive (1859 - 2008)My Account »
ALTHOUGH WILLIAM Osler may have said that one of the first duties of a doctor is to educate the masses not to take medicine, drugs are a key component of modern healthcare. However, drug costs in the Republic have risen inexorably in recent times to the point where the State’s spend on pharmaceuticals is among the highest in Europe. Between 1997 and 2007, the annual cost of drugs under the community drugs schemes reached €1.74 billion, a 500 per cent increase. This level of growth was unsustainable and the announcement by the Minister for Health this week of drug cost savings is therefore most welcome.
According to the Irish Pharmaceutical Healthcare Association (IPHA), with which the Minister negotiated the new deal, many people will now see savings of €3-€4 for each €10 they spent on drugs before the change. A patient paying for the cholesterol lowering drug pravastatin will see the monthly cost drop from €24 to just over €14. Perhaps of greatest economic significance is the drop in price of proton pump inhibitors. These drugs are used to treat peptic ulcers; collectively, three medicines from this family of drugs feature in the top six most costly medications dispensed to medical card patients in 2007. Now, a person prescribed Omeprazole, the original proton pump inhibitor, will pay €13.41 for a month’s supply, down from €22.35.
